According to the ICMR report, the survey found 87.5% samples of Acinetobacter baumannii tested in 2021 were resistant to carbapenems, which is a high-end antibiotic. This, researchers said, limited the treatment option in individuals suffering from infection caused by the bacteria.
from Times of India https://ift.tt/dDT57nz
No comments:
Post a Comment